HK1129835A1 - Subcutaneous implants releasing an active principle over an extended period of time - Google Patents

Subcutaneous implants releasing an active principle over an extended period of time

Info

Publication number
HK1129835A1
HK1129835A1 HK09107201.1A HK09107201A HK1129835A1 HK 1129835 A1 HK1129835 A1 HK 1129835A1 HK 09107201 A HK09107201 A HK 09107201A HK 1129835 A1 HK1129835 A1 HK 1129835A1
Authority
HK
Hong Kong
Prior art keywords
time
subcutaneous implants
extended period
active principle
principle over
Prior art date
Application number
HK09107201.1A
Other languages
English (en)
Inventor
Patrice Mauriac
Pierre Marion
Original Assignee
Mediolanum Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mediolanum Pharmaceuticals Ltd filed Critical Mediolanum Pharmaceuticals Ltd
Publication of HK1129835A1 publication Critical patent/HK1129835A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Prostheses (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
HK09107201.1A 2006-08-02 2009-08-05 Subcutaneous implants releasing an active principle over an extended period of time HK1129835A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT001545A ITMI20061545A1 (it) 2006-08-02 2006-08-02 Particelle in grado di rilasciare il principio attivo per un periodo prolungato di tempo
PCT/EP2007/057969 WO2008015238A2 (en) 2006-08-02 2007-08-01 Subcutaneous implants releasing an active principle over an extended period of time

Publications (1)

Publication Number Publication Date
HK1129835A1 true HK1129835A1 (en) 2009-12-11

Family

ID=37846057

Family Applications (1)

Application Number Title Priority Date Filing Date
HK09107201.1A HK1129835A1 (en) 2006-08-02 2009-08-05 Subcutaneous implants releasing an active principle over an extended period of time

Country Status (18)

Country Link
US (1) US20100003298A1 (xx)
EP (1) EP2054037B1 (xx)
JP (1) JP2009545564A (xx)
KR (1) KR20090037946A (xx)
CN (1) CN101553212A (xx)
AT (1) ATE451913T1 (xx)
AU (1) AU2007280397A1 (xx)
BR (1) BRPI0714515A2 (xx)
CA (1) CA2659441A1 (xx)
DE (1) DE602007003854D1 (xx)
EA (1) EA017292B1 (xx)
ES (1) ES2337419T3 (xx)
HK (1) HK1129835A1 (xx)
IT (1) ITMI20061545A1 (xx)
MX (1) MX2009001232A (xx)
PL (1) PL2054037T3 (xx)
PT (1) PT2054037E (xx)
WO (1) WO2008015238A2 (xx)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2717459A1 (en) * 2008-03-20 2009-09-24 N.V. Organon Preparation of a pharmaceutical composition for increasing bone mineral density

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1311686C (en) * 1986-06-25 1992-12-22 John Weldon Shell Controlled release bioerodible drug delivery system
US5490962A (en) * 1993-10-18 1996-02-13 Massachusetts Institute Of Technology Preparation of medical devices by solid free-form fabrication methods
US5942253A (en) * 1995-10-12 1999-08-24 Immunex Corporation Prolonged release of GM-CSF
US5817343A (en) * 1996-05-14 1998-10-06 Alkermes, Inc. Method for fabricating polymer-based controlled-release devices
IT1304152B1 (it) * 1998-12-10 2001-03-08 Mediolanum Farmaceutici Srl Composizioni comprendenti un peptide ed acido polilattico-glicolicoatte alla preparazione di impianti sottocutanei aventi un prolungato
KR20060027353A (ko) * 2003-06-26 2006-03-27 메디올라늄 파마슈티컬즈 리미티드 활성 성분의 초기 방출이 제한되고 후속의 연장된 방출이선형적으로 변화하는 피하 삽입물
US20050266067A1 (en) * 2004-03-02 2005-12-01 Shiladitya Sengupta Nanocell drug delivery system

Also Published As

Publication number Publication date
EP2054037B1 (en) 2009-12-16
WO2008015238A3 (en) 2008-03-20
US20100003298A1 (en) 2010-01-07
EA017292B1 (ru) 2012-11-30
MX2009001232A (es) 2009-04-28
EP2054037A2 (en) 2009-05-06
WO2008015238A8 (en) 2008-06-05
AU2007280397A1 (en) 2008-02-07
ITMI20061545A1 (it) 2008-02-03
WO2008015238A2 (en) 2008-02-07
EA200900247A1 (ru) 2009-06-30
CN101553212A (zh) 2009-10-07
ATE451913T1 (de) 2010-01-15
PT2054037E (pt) 2010-03-24
DE602007003854D1 (de) 2010-01-28
PL2054037T3 (pl) 2010-05-31
BRPI0714515A2 (pt) 2013-04-24
CA2659441A1 (en) 2008-02-07
JP2009545564A (ja) 2009-12-24
ES2337419T3 (es) 2010-04-23
KR20090037946A (ko) 2009-04-16

Similar Documents

Publication Publication Date Title
WO2006127681A3 (en) Delivery systems for managing release of functional ingredients in an edible composition
UA100851C2 (ru) Средство для борьбы с паразитами на животных
AR050118A1 (es) Composiciones orales y sistemas de liberacion
CR20110042A (es) Forma cristalina de (2s)-(-)-n-(6-cloro-2,3-dihidro-benzo [1,4]dioxin-2-ilmetil)-sulfamida
IL178390A0 (en) Methods and compositions for the treatment, prevention or management of dysfunctional sleep and dysfunctional sleep associated with disease
TW200621268A (en) Antimicrobial copolymers and uses thereof
TW200630128A (en) Active ingredient-containing silicone elastomers
UY32503A (es) Formulación pesticida de uso agrícola a base de avermectina y un agente fotoprotector
ATE551077T1 (de) Minderung einer infektion in zusammenhang mit einer medizinischen vorrichtung
EA200900246A1 (ru) Подкожные имплантаты, высвобождающие активный компонент в течение продолжительного периода времени
JP2008518699A5 (xx)
MX362908B (es) Implantes que contienen fármacos y métodos de uso de los mismos.
WO2006099232A3 (en) Antimicrobial pet wipes
AR076139A1 (es) Metodo para el tratamiento de cultivos con un pesticida encapsulado.
TW200635616A (en) Organic compounds
BRPI0518855A2 (pt) medicamento para aplicaÇço higiÊnica no ouvido
EP1731609A4 (en) INHIBITOR OF THE EXPRESSION OF RAD51, MEDICAMENT CONTAINING THE INHIBITOR AS ACTIVE INGREDIENT AND USE THEREOF
UY29236A1 (es) 2-alcoxi-3,4,5-trihidroxi-alquilamidas. su preparación, composiciones que las contienen y su utilización.
MX2009001231A (es) Implantes subcutaneos que liberan un principio activo durante un periodo de tiempo extendido.
UA92604C2 (ru) Композиция стансопорфина с физиологической осмотической концентрацией и ее применение
EP2006287A4 (en) COMPOUND HAVING ANTIMALARIAL ACTIVITY AND ANTIMALARIAL DRUG CONTAINING IT AS AN ACTIVE SUBSTANCE
HK1129835A1 (en) Subcutaneous implants releasing an active principle over an extended period of time
MX2010001221A (es) La aplicacion de 5-metil-1,3 benzenediol o derivados del mismo, en la preparacion de medicinas y alimentos funcionales para el tratamiento o prevencion de la depresion.
BRPI0612813A2 (pt) copolímero, composição perfumante, e, artigo perfumado
ZA201005394B (en) 15,16-methylene-17-hydroxy-19-nor-21-carboxylic acid y-lactone derivative,use thereof,and medicament containing said derivative

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20170801